ArticleJournal of experimental & clinical cancer research : CR2026
Gemcitabine-induced β4 integrin drives cancer progression and gemcitabine resistance in pancreatic cancer.
Yoshinobu Kariya et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.